Atea Pharmaceuticals Q3 EPS $(0.53) Misses $(0.44) Estimate
Benzinga Newsdesk 11 months ago
EarningsEarnings MissesNews
Atea Pharmaceuticals (NASDAQ:AVIR) reported quarterly losses of $(0.53) per share which missed the analyst consensus estimate of $(0.44) by 20.45 percent. This is a 43.24 percent decrease over losses of $(0.37) per share
Atea Pharmaceuticals (NASDAQ:AVIR) reported quarterly losses of $(0.53) per share which missed the analyst consensus estimate of $(0.44) by 20.45 percent. This is a 43.24 percent decrease over losses of $(0.37) per share from the same period last year.